The pharmaceutical industry is now waging a broad-based assault on Biden's Inflation Reduction Act, including the measure to negotiate Medicare drug prices — just as the negotiations are about to begin. Via the New York Times: On Tuesday, Johnson & Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a halt to the drug pricing program.